Guidance with intravascular ultrasound (IVUS) for the endovascular treatment of femoropopliteal artery (FPA) disease using a drug-coated balloon (DCB) is significantly associated with improved 12-month clinical outcomes, especially in patients who have complex FPA lesions, a subgroup analysis of the IVUS-DCB trial shows.